Article
Mapping partner drug resistance to guide antimalarial combination therapy policies in sub-Saharan Africa.
Proceedings of the National Academy of Sciences of the United States of America - 20 Jul 2021
Ehrlich Hanna Y, Bei Amy K, Weinberger Daniel M, Warren Joshua L, Parikh Sunil
Abstract excerpt
Resistance to artemisinin-based combination therapies (ACTs) threatens the global control of Plasmodium falciparum malaria. ACTs combine artemisinin-derived compounds with partner drugs to enable multiple mechanisms of clearance. Although ACTs remain widely effective in sub-Saharan Africa, long-standing circulation of parasite alleles associated with reduced partner drug susceptibility may contribute to the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
